Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FTDZX vs. BIB: which is better?

Bottom line

FTDZX vs BIB: the short answer

FTDZX (Franklin Biotechnology Discovery Fund) and BIB (ProShares Ultra Nasdaq Biotechnology) are both mutual funds.

But BIB is far broader, holding 267 positions to 126 for FTDZX, so beyond the top names it adds exposure FTDZX doesn't have.

FTDZX is cheaper at 0.76% vs 0.95% — a difference of $19 a year per $10,000 invested.

Over five years, FTDZX returned +6.4% a year vs −1.0% for BIB.

Updated Nov 19, 2026

FTDZX vs BIB side by side

FTDZXBIB
TypeMutual fundETF
Fund familyFranklin TempletonProShares
CategoryTechnology SectorTechnology Sector
Expense ratio0.76%0.95%
Annual cost per $10k$76$95
10-yr cost on $10k (prospectus)$954$1,401
Max front load0%None
12b-1 fee0%—
1-yr return+52.7%+59.3%
5-yr return (annualized)+6.4%−1.0%
10-yr return (annualized)+7.2%+1.4%
Best quarter—+56.2%
Worst quarter—−42.7%
Net assets (fund)$1.2B$73.7M
Number of holdings126267
Portfolio turnover38%29%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

8 of FTDZX's top 25 holdings also appear in BIB's top 25.

Shared top holdings
HoldingFTDZXBIB
Amgen, Inc.4.39%4.48%
Gilead Sciences, Inc.3.86%4.66%
Regeneron Pharmaceuticals, Inc.3.77%3.21%
Argenx SE3.62%1.19%
Vertex Pharmaceuticals, Inc.3.54%4.65%
Revolution Medicines, Inc.3.01%1.57%
Guardant Health, Inc.2.76%0.85%
Insmed, Inc.1.99%1.16%

Source: SEC Form N-PORT

FTDZX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

BIB top 10

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. Gilead Sciences, Inc. — 4.66%
  4. Vertex Pharmaceuticals, Inc. — 4.65%
  5. Amgen, Inc. — 4.48%
  6. N/a — 3.94%
  7. N/a — 3.26%
  8. Regeneron Pharmaceuticals, Inc. — 3.21%
  9. N/a — 2.62%
  10. Alnylam Pharmaceuticals, Inc. — 2.01%

FAQ

What is the difference between FTDZX and BIB?
FTDZX (Franklin Biotechnology Discovery Fund) and BIB (ProShares Ultra Nasdaq Biotechnology) are both mutual funds. But BIB is far broader, holding 267 positions to 126 for FTDZX, so beyond the top names it adds exposure FTDZX doesn't have.
Which is cheaper, FTDZX or BIB?
FTDZX has the lower expense ratio (0.76%).
Should I own both FTDZX and BIB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.